Home > Healthcare > Medical Devices > Diagnostic Devices > Sexual Health Testing Market

Sexual Health Testing Market Share

Report ID: GMI5799
Published Date: May 2023
Report Format: PDF

Download Free Sample

Sexual Health Testing Market Share

Some of the notable key industry players operating in the sexual health testing market include

bioMérieux SA
Hologic, Inc.
OraSure Technologies, Inc.
Bio-Rad Laboratories, Inc.
Abbott Laboratories
Merck & Co. Inc.
Johnson & Johnson Services, Inc
GlaxoSmithKline Plc.
Allergen
Bayer AG
Bristol-Myers Squibb Company
Bausch Health Companies Inc.
Boehringer Ingelheim International GmbH
Sorrento Therapeutics, Inc.
WEX Pharmaceuticals Inc.
Zynerba Pharmaceuticals, Inc.
Medtronic Inc.
Boston Scientific Corporation
Halyard Health, Inc.
Neurotech Na, Inc.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for sexual health testing was more than USD 90 billion in 2022 and will reach over USD 150 billion by 2032 propelled by the high prevalence of sexually transmitted diseases (STDs) across the world.

STD diagnostics market from Laboratory devices segment will surpass USD 100 billion by 2032 with an increase in device availability coupled with several businesses focusing on creating innovative technology.

Chlamydia application segment will reach over USD 36 billion by 2032 owing to the increased prevalence of chlamydia over the forecast years.

U.S. sexual health testing market will grow momentously to more than USD 55 billion by the 2032 on account of high spending on healthcare management and rising disposable income in the country.